Evaluation of molecular receptors status in breast cancer using an mpMRI-based feature fusion radiomics model: mimicking radiologists' diagnosis
Shengsheng Lai,Fangrong Liang,Wanli Zhang,Yue Zhao,Jiamin Li,Yandong Zhao,Yongzhou Xu,Wenshuang Ding,Jie Zhan,Xin Zhen,Ruimeng Yang
DOI: https://doi.org/10.3389/fonc.2023.1219071
IF: 4.7
2023-11-22
Frontiers in Oncology
Abstract:Objective: To investigate the performance of a novel feature fusion radiomics (R FF ) model that incorporates features from multiparametric MRIs (mpMRI) in distinguishing different statuses of molecular receptors in breast cancer (BC) preoperatively. Methods: 460 patients with 466 pathology-confirmed BCs who underwent breast mpMRI at 1.5T in our center were retrospectively included hormone receptor (HR) positive (HR+) (n=336) and HR negative (HR-) (n=130). The HR- patients were further categorized into human epidermal growth factor receptor 2 (HER-2) enriched BC (HEBC) (n=76) and triple negative BC (TNBC) (n=54). All lesions were divided into a training/validation cohort (n=337) and a test cohort (n=129). Volumes of interest (VOIs) delineation, followed by radiomics feature extraction, was performed on T2WI, DWI 600 (b=600 s/mm 2 ), DWI 800 (b=800 s/mm 2 ), ADC map, and DCE 1-6 (six continuous DCE-MRI) images of each lesion. Simulating a radiologist's work pattern, 150 classification base models were constructed and analyzed to determine the top four optimum sequences for classifying HR+ vs . HR-, TNBC vs . HEBC, TNBC vs . non-TNBC in a random selected training cohort (n=337). Building upon these findings, the optimal single sequence models (Rss) and combined sequences models (R FF ) were developed. The AUC, sensitivity, accuracy and specificity of each model for subtype differentiation were evaluated. The paired samples Wilcoxon signed rank test was used for performance comparison. Results: During the three classification tasks, the optimal single sequence for classifying HR+ vs . HR- was DWI 600 , while the ADC map, derived from DWI 800 performed the best in distinguishing TNBC vs . HEBC, as well as identifying TNBC vs . non-TNBC, with corresponding training AUC values of 0.787, 0.788, and 0.809, respectively. Furthermore, the integration of the top four sequences in R FF models yielded improved performance, achieving AUC values of 0.809, 0.805 and 0.847, respectively. Consistent results was observed in both the training/validation and testing cohorts, with AUC values of 0.778, 0.787, 0.818 and 0.726, 0.773, 0.773, respectively (all p < 0.05 except HR+ vs . HR-). Conclusion: The R FF model, integrating mpMRI radiomics features, demonstrated promising ability to mimic radiologists' diagnosis for preoperative identification of molecular receptors of BC.
oncology